The proposed bill amends existing legislation regarding health insurance benefits related to insulin drugs and supplies, while also introducing a new chapter to the North Dakota Century Code focused on prescription drug transparency reporting under the federal drug discount program. The bill deletes the previous section 54-52.1-04.18, which outlined health insurance coverage for insulin drugs and medical supplies, and instead establishes a framework for reporting requirements for health care facilities, contract pharmacies, drug manufacturers, health insurers, and pharmacy benefits managers participating in the federal program.

Key provisions of the new chapter include definitions of relevant terms, annual reporting requirements for various entities, and the establishment of civil penalties for violations. The bill mandates that participating entities report on how their involvement in the program benefits their communities, the financial incentives received from drug manufacturers, and the overall savings generated from the program. Additionally, it emphasizes the confidentiality of the reports submitted while allowing the commissioner to disclose summaries of the findings. The act is set to take effect for health care facilities on January 1, 2026, and for other entities on January 1, 2027.

Statutes affected:
INTRODUCED: 54-52.1-04.18
Adopted by the Senate Human Services Committee: 54-52.1-04.18
FIRST ENGROSSMENT: 54-52.1-04.18